No change seen in proportion of adults unaware they had diabetes or high cholesterol levels
Read More »HealthDay.com
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
Longer mean duration of quality-adjusted time without symptoms of disease progression or toxicity of treatment seen with dostarlimab
Read More »Artificial Sweetener Neotame Found in Most E-Cigarettes
Authors say toxicity, respiratory, and systemic health effects during heating in an e-cigarette are unknown
Read More »Texas Woman Dies After Using Tap Water in Sinus Rinse
By I. Edwards HealthDay ReporterMONDAY, June 9, 2025 (HealthDay News) — A Texas woman has died after using tap water in a sinus rinse, leading to a rare but often fatal brain infection, health officials report.The 71-year-old woman died from a condition called primary amebic meningoencephalitis (PAM), which is caused …
Read More »Drop in Mental Health Scores Seen With Primary Open-Angle Glaucoma Diagnosis
Mean pre-POAG and post-POAG Visual Function Questionnaire-25 scores decreased from 94.5 to 88.0
Read More »Better Adherence to Antipsychotics Linked to Lower Vehicle Crash Risk
Perfect adherence to medication linked to half the odds of a crash compared with complete nonadherence
Read More »Doctors Favor CPAP, Patients Favor Tirzepatide for Comorbid Obesity, Sleep Apnea
If evidence demonstrates equal effectiveness, providers favor CPAP, while patients lean toward tirzepatide
Read More »Early Dog Exposure May Modify Genetic Effect on Atopic Eczema Risk
Findings support observational epidemiology showing protective effect of dog exposure early in life
Read More »American Society of Clinical Oncology, May 31-June 3
By Beth Gilbert HealthDay ReporterThe annual meeting of the American Society of Clinical Oncology was held from May 31 to June 3 in Chicago and hosted more than 35,000 participants, including clinicians, academicians, allied health professionals, and others interested in oncology. The conference featured the latest advances in clinical cancer research, including …
Read More »Long-Lasting HIV Prevention Shot Headed Toward Approval
By I. Edwards HealthDay ReporterFRIDAY, June 6, 2025 (HealthDay News) — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.If approved, the shot — lenacapavir — would be given twice a year and could be a big …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.